1. Cost Considerations in the Drug Treatment of Hypertension

   • Norman M. Kaplan

   Current Opinion 17 November 2012 Pages: 283 - 285

2. Drug Utilisation Patterns in the Third World

   • Jawahar S. Bapna
   • Chakra D. Tripathi
   • Uma Tekur

   Leading Article 17 November 2012 Pages: 286 - 294

3. Treatment of Urinary Tract Infection

   • Richard J. Plumridge
   • Clayton L. Golledge

   Review Article 17 November 2012 Pages: 295 - 306

4. Clinical and Economic Factors in the Treatment of Onychomycosis

   • Thomas R. Einarson
   • Aditya K. Gupta
   • Steve Arikian

   Review Article 17 November 2012 Pages: 307 - 320

5. Do Physicians’ Perceptions of Drug Costs Influence Their Prescribing?

   • Mandy Ryan
   • Brian Yule
   • Ross J. Taylor

   Original Research Article 17 November 2012 Pages: 321 - 331

6. The Economic Costs of Caring for People with HIV Infection and AIDS in England and Wales

   • Stavros Petrou
   • Mary Dooley
   • Adrian Renton

   Original Research Article 17 November 2012 Pages: 332 - 340

7. The November 1995 Revised Australian Guidelines for the Economic Evaluation of Pharmaceuticals

   • Paul C. Langley

   Special Article 17 November 2012 Pages: 341 - 352

8. Industry Comment on the 1995 Revised Australian Pharmacoeconomic Guidelines

   • Mendel P. Grobler
   • Kelly Macarounas-Kirchmann
   • Michael Stafford

   Special Article 17 November 2012 Pages: 353 - 356

9. Granisetron

   • Greg L. Plosker
   • Paul Benfield

   Pharmacoeconomic Drug Evaluation 17 November 2012 Pages: 357 - 374